From European Public Health Association
Prevention is the foundation of public health policy and central to protecting and improving people’s health and well-being. Europe’s Beating Cancer Plan is a key opportunity to put prevention where it belongs – at the heart of the European Union’s (EU) health agenda.
Tackling socially determined inequalities in health, both between and within European Union (EU) Member States, is still a major challenge. This analysis describes the main concepts and gives examples for health inequalities across the EU. It then presents an overview of the work accomplished at international and EU levels. It shows, in particular, how the EU institutions, bodies and agencies have contributed to reducing health inequalities, notwithstanding that Member States have the main responsibility for health policy. The analysis then goes on to depict stakeholder views, before closing with an outlook on avenues for further action.
In a meeting held in Brussels last 6th February, the Commission introduced a new project to provide technical assistance to the ERNs for the development, appraisal and implementation of Clinical Practice Guidelines (CPGs) and Clinical Decision Support Tools (CDSTs). This 4 years contract will enable the ERNs to adopt a common methodology and develop their own decision-making tools: 48 new CPGs are expected and 120 existing CPGs will be adapted to the specific rare diseases they are addressing.
In light of Rare Diseases Day 2020, EU40 is a delight to co-organise Phil L. Herold’s exhibition inside the European Parliament, an exhibition of artwork and life.
The opening reception of the exhibition will take place on February 18th at the European Parliament, 5G Space.
This event will be hosted by MEP Stelios Kympouropoulos, MEP Tomislav Sokol, and MEP Loucas Fourlas. We will count on the presence and welcome words of Commissioner for Health and Food Safety, Stella Kyriakides to open this inclusive initiative and have the chance to witness a performance by soprano Noémie Desquiotz Sunnen, living with ALS.
Co-hosted by MEP Claudia Gamon & MEP Tomislav Sokol.
Europe’s Beating Cancer Plan is expected by the end of the year, and preparatory work and consultations are currently ongoing to shape the plan, set priorities and outline future action. This workshop looks into one of the key topics, modifiable risk factors and cancer prevention. Experts from all across the cancer spectrum will discuss with MEPs the state of play and main challenges, with a special angle on paediatric, digestive and HPV cancers.
Today, on World Cancer Day, the European Commission is launching an EU-wide public consultation on Europe’s Beating Cancer Plan. The consultation will help shape the Plan, identify key areas, and explore future action.
EMA’s human medicines committee (CHMP) has recommended granting a marketing authorisation in the European Union (EU) for Givlaari (givosiran), the first treatment for acute hepatic porphyria (AHP) in adults and adolescents aged 12 years and older.
On 4 February 2020, on the occasion of World Cancer Day, the European Commission will initiate a broad stakeholder debate on the proposed Europe’s Beating Cancer plan, to be rolled out towards the end of the year. The launch event will be held in the European Parliament in Brussels, supported by the MEPs Against Cancer Interest Group. It will bring together political leaders, representatives from international organisations, health ministries, leading academics, scientists and health professionals, the private sector and non-governmental organisations, and cancer patients and survivors.